Birth outcomes in women who have taken adalimumab in pregnancy: A prospective cohort study

Background Information is needed on the safety of adalimumab when used in pregnancy for the treatment of certain autoimmune diseases. Methods and findings Between 2004 and 2016, the Organization of Teratology Information Specialists Research Center at the University of California San Diego conducted...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Christina Chambers, Diana L. Johnson, Ronghui Xu, Yunjun Luo, Janina Lopez-Jimenez, Margaret P Adam, Stephen R. Braddock, Luther K. Robinson, Keith K. Vaux, Kenneth Lyons Jones
Format: Artigo
Idioma:anglès
Publicat: 2019
Accés en línia:https://doi.org/10.1371/journal.pone.0223603
https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0223603&type=printable
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!